NasdaqGS:MRNABiotechs
How Investors Are Reacting To Moderna (MRNA) CEPI Funding For Its Ebola Vaccine Program
In recent days, Moderna announced an expanded collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI), which will provide up to US$50 million to support preclinical and Phase 1 development of its investigational Bundibugyo ebolavirus (BDBV) vaccine candidate.
This partnership highlights how Moderna is using its mRNA platform beyond respiratory viruses, extending into emerging infectious diseases such as Ebola during an active outbreak in the Democratic Republic of...